Glossary
Experimental or investigational
A plan label for treatments it considers not yet proven safe and effective, which it excludes from coverage even when a doctor recommends them.
Also called: experimental treatment, investigational treatment, experimental exclusion, unproven treatment
"Experimental" or "investigational" is a reason plans give for refusing to pay for a drug, device or procedure. Most plan contracts exclude treatments they classify this way, and they define the term themselves. Common tests include whether the U.S. Food and Drug Administration has approved the item for that use, whether published peer-reviewed studies show it works, and whether major medical bodies accept it as standard care.
Disputes often involve new therapies, off-label drug uses, genetic tests and treatments for rare diseases. A denial on this basis is a different argument from medical necessity: the plan is saying the treatment is unproven, not that you do not need care. As a labeled hypothetical, a plan covers a drug for the condition on its FDA label but excludes the same drug for another condition, calling it investigational, while your specialist cites studies supporting its use.
You can respond with the studies and a doctor's letter, and ask for the plan's written policy. Under the Affordable Care Act, non-grandfathered plans generally must cover the routine costs of care for people enrolled in approved clinical trials, though not the experimental item itself. The common mistake is accepting the label as final. A claim denial on these grounds can be appealed, and some state and federal external review rules reach it.
Last reviewed November 16, 2026